IP Library Granted Patent US 9,222,949
Granted Patent B2
US 9,222,949 · App. 12/662,651 · Granted Dec 29, 2015

Salvinorin immunoassay

Inventors: Stephen P. Fitzgerald (Crumlin, GB); Robert I. McConnell (Crumlin, GB); Philip A. Lowry (Crumlin, GB); Elouard Benchikh (Crumlin, GB)
Assignee: RANDOX LABORATORIES, LTD.
G01N33/94C07K16/16G01N33/946
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,222,949
App. No.
12/662,651
Granted
Dec 29, 2015
Kind
B2
Abstract

The present invention provides an immunoassay method for detecting or determining the amount of salvinorin A, salvinorin B and/or analogues thereof in an in vitro sample, an antibody for salvinorin A, salvinorin B and/or analogues thereof and a kit for detecting the presence of or determining the amount of salvinorin A, salvinorin B and its analogues thereof in a sample.

Claims (11)

1. A method for detecting or determining the amount of salvinorin A, salvinorin B, and/or a C-9 analogue of salvinorin A and/or salvinorin B in an in vitro sample, the method comprising:

contacting the sample with a conjugate and an antibody,

detecting conjugate bound to salvinorin A, salvinorin B, and/or a C-9 analogue of salvinorin A and/or salvinorin B, and

deducing from a calibration curve the presence or the amount of salvinorin A, salvinorin B, and/or a C-9 analogue of salvinorin A and/or salvinorin B,

wherein;

the antibody is raised from an immunogen of the following structure:

wherein accm is an antigenicity-conferring carrier material and the crosslinker joins the O-atom at C-9 of the tricyclic fused ring to the accm; and

the conjugate comprises a reporter group that is linked to the O-atom at C-9 of the tricyclic fused ring of salvinorin B.

2. The method of claim 1 , wherein the crosslinker is —(X) n —Y—Z—, where n=0 or 1, and if present, X is selected from the group consisting of carbonyl, thiocarbonyl, oxycarbonyl and oxythiocarbonyl; Y is a C 1- C 10 substituted or unsubstituted straight chain or saturated alkylene moiety or arylene moiety and Z is selected from the group consisting of a carbonyl group or an amino group.

3. The method of claim 2 , wherein Y is a C 2 -C 6 substituted or unsubstituted straight chain or saturated alkylene moiety or an arylene moiety.

4. The method of claim 1 , wherein the C-9 analogue is 9-methoxymethyl ethersalvinorin B or 9-ethoxymethylethersalvinorin B.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVENYANCE PREVIOUSLY RECORDED AT REEL: 055950 FRAME: 0471. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 20, 2021
From: RANDOX LABORATORIES LIMITED
To: NORTHERN BANK LIMITED
Reel/Frame 056210/0055 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2021
From: RANDOX LABORATORIES LIMITED
To: NORTHERN BANK LIMITED
Reel/Frame 055950/0471 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2010
From: FITZGERALD, STEPHEN PETER; MCCONNELL, ROBERT IVAN; LOWRY, PHILIP ANDREW; BENCHIKH, ELOUARD
To: RANDOX LABORATORIES, LTD.
Reel/Frame 024743/0730 →
Priority Claims (1)
EP 09159094 · Apr 29, 2009 · regional
Continuity (1)
Related Publication 20100291600A1 · Nov 18, 2010